A Pilot Trial of Jawarish Amla as Adjuvant to Anti-Tubercular Treatment Drugs for Control of Adverse Reactions in DOTS Regime in Pulmonary TB

BACKGROUND AND OBJECTIVES: One of the greatest challenges of health care systems at the dawn of the 21st century is tuberculosis (TB). Drug resistant strains of TB are becoming a global public health risk. These strains commonly appear due to faulty therapies. Patients frequently stop treatment due...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherwani, Arish Mohammad Khan, Zulkifle, Mohammad, Rehmatulla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Islamic Medical Association of North America 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708637/
https://www.ncbi.nlm.nih.gov/pubmed/23864996
http://dx.doi.org/10.5915/44-1-9988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708637/
https://www.ncbi.nlm.nih.gov/pubmed/23864996
http://dx.doi.org/10.5915/44-1-9988

Ejemplares similares